Optimising pneumonia vaccine programmes: a strategic opportunity for child survival and lifelong lung health.

Greenslade L, Secure PCV and Stop RSV Collaborators

Open source

DOI
10.1016/j.langlo.2026.104064
Published
2026 Aug 14
Container
The Lancet. Global health
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.langlo.2026.104064,
  title = {Optimising pneumonia vaccine programmes: a strategic opportunity for child survival and lifelong lung health.},
  author = {Greenslade L and Secure PCV and Stop RSV Collaborators},
  year = {2026},
  journal = {The Lancet. Global health},
  doi = {10.1016/j.langlo.2026.104064},
  url = {https://doi.org/10.1016/j.langlo.2026.104064}
}

RIS

TY  - JOUR
TI  - Optimising pneumonia vaccine programmes: a strategic opportunity for child survival and lifelong lung health.
AU  - Greenslade L
AU  - Secure PCV and Stop RSV Collaborators
PY  - 2026
JO  - The Lancet. Global health
DO  - 10.1016/j.langlo.2026.104064
UR  - https://doi.org/10.1016/j.langlo.2026.104064
ER  - 

APA

L, G., & Collaborators, S. P. A. S. R. (2026). Optimising pneumonia vaccine programmes: a strategic opportunity for child survival and lifelong lung health.. The Lancet. Global health. https://doi.org/10.1016/j.langlo.2026.104064

Source records